awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51832606-3D4FBACF-8D73-4723-9EBB-315CCF8EDF77
Q51832606-3D4FBACF-8D73-4723-9EBB-315CCF8EDF77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51832606-3D4FBACF-8D73-4723-9EBB-315CCF8EDF77
Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma.
P2860
Q51832606-3D4FBACF-8D73-4723-9EBB-315CCF8EDF77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51832606-3D4FBACF-8D73-4723-9EBB-315CCF8EDF77
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e63ed7641afc64af874acab869fce9b0c2b27335
P2860
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.